Is a pre-operative glycaemic target HbA1c of 69mmol/mol achievable? A single-centre experience.
Uppal C, Blanshard A, Ahluwalia R, Dhatariya K.
Diabetes Therapy. 2019;10(5):1959-1967
Diabetes Therapy. 2019;10(5):1959-1967
Recruitment, retention, and training of people with type 2 diabetes as diabetes prevention mentors (DPM) to support a healthcare professional-delivered diabetes prevention program: the Norfolk Diabetes Prevention Study (NDPS).
Garner NJ, Pascale M, France K NDPS Group, On behalf of NDPS Group.
BMJ Open Diabetes Research and Care 2019;7:e000619
BMJ Open Diabetes Research and Care 2019;7:e000619
The incidence of euglycaemic diabetic ketoacidosis in adults with type 1 diabetes in the UK prior to the widespread use of sodium glucose co-transporter 2 inhibitors.
Macfarlane J, Dhatariya K.
Mayo Clinic Proceedings 2019;94(9):1909-1910
Mayo Clinic Proceedings 2019;94(9):1909-1910
The effects of hypoglycemia and dementia on serious adverse events in older people – a retrospective cohort study.
Mattishent K, Richardson K, Dhatariya K, Savva G, Fox C, Loke Y.
Diabetes Obesity and Metabolism 2019;21(9):2076-2085
Diabetes Obesity and Metabolism 2019;21(9):2076-2085
The cost of treating diabetic ketoacidosis in an adolescent population in the UK: a national survey of hospital resource use.
Dhatariya KK, Parsekar K, Skedgel C, Datta V, Hill P, Fordham R.
Diabetic Medicine 2019;36(8):982-987
Diabetic Medicine 2019;36(8):982-987
Does the use of a colour coded inpatient capillary blood glucose monitoring chart influence outcomes?
Sharma D, Gerlach M, Sharma V, Dhatariya KK.
British Journal of Diabetes 2019;19(1):19-24
British Journal of Diabetes 2019;19(1):19-24
A survey of the management of 16 to 18 year olds presenting with diabetic ketoacidosis in the UK – A need for standardisation.
Dhatariya K, Winocour P, Raffles A.
British Journal of Diabetes 2019;19(1):29-33
British Journal of Diabetes 2019;19(1):29-33
The impact of liraglutide on diabetes-related foot ulceration and associated complications in patients with type 2 diabetes at high risk for cardiovascular events: results from the LEADER trial.
Dhatariya K, Bain SC, Buse JB, Simpson R, Tarnow L, Kaltoft MS, Stellfeld M, Tornøe K, Pratley RE, the LEADER Publication Committee on behalf of the LEADER Trial Investigators.
Diabetes Care 2018;41(10):2229-2235
Diabetes Care 2018;41(10):2229-2235
Self-management of diabetes in hospital. A guideline from the Joint British Diabetes Society Inpatient Care Group.
Flanagan D, Dhatariya K, Kilvert A on behalf of the Joint British Diabetes Societies In Patient group.
Diabetic Medicine 2018;35(8):992-996
Diabetic Medicine 2018;35(8):992-996
Managing hyperglycaemia during antenatal steroid administration, labour and birth in pregnant women with diabetes.
Dashora U, Temple R, Murphy H, Stanley K, Castro E, George S, Dhatariya K, Haq M, Sampson M on behalf of the Joint British Diabetes Societies In Patient group.
Diabetic Medicine 2018;35(8):997-1004
Diabetic Medicine 2018;35(8):997-1004
Self-management of diabetes in hospital. Management of hyperglycaemia and steroid (glucocorticoid) therapy.
Roberts A, James J, Dhatariya K on behalf of the Joint British Diabetes Societies In Patient group.
Diabetic Medicine 2018;35(8):1011-1017
Diabetic Medicine 2018;35(8):1011-1017
Familial insulinomatosis and diabetes mellitus due to a missense MAFA mutation.
Iacovazzo D, Flanagan SE, Quezado R, Walker E, Caswell R, de Sousa Barroa F, Johnson M, Wakeling M, Guo M, Dang MN, Gabrovska P, Brändle M, Niederle B, Christ E, Jenni S, Sipos B, Nieser M, Frilling A, Dhatariya K, Chanson P, de Herder W, Konukiewitz B, Klöppel G, Stein R, Korbonits M, Ellard S.
Proceedings of the National Academy of Science 2018;115(5):1027-1032
Proceedings of the National Academy of Science 2018;115(5):1027-1032